Abschluss eines nicht exklusiven Rabattvertrages nach§ 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Testosteron (ATC: G03BA03) innerhalb des Zeitraumes vom 01.12.2026 bis zum 30.11.2028 mit jederzeitiger Möglichkeit des Vertragsabschlusses während der Laufzeit („open-house-Modell“).

TENDER DESCRIPTION

For the active ingredient Testosterone (ATC: G03BA03), AOK Niedersachsen offers the service. For the period until the entry into force of exclusive contracts as a result of a formal procurement procedure in accordance with the rules of Part 4 of the GWB, AOK Niedersachsen offers, to all interested pharmaceutical companies, without a selection decision, discount contracts. The contract awards are carried out within the scope of an “open-house model” and serve as a bridge between the start of generic competition (expiry of patents) and the award of exclusive contracts. The contracts offered are non-exclusive; AOK Niedersachsen wishes contracts with all market participants (pharmaceutical companies). Under the open-house model, uniform terms apply to all participants. Contract contents, terms and conditions, and access procedures are uniform—individual negotiations are generally not conducted. The contract terms are a maximum of twenty-four months; the earliest contract start date is 01.12.2026. All contracts end no later than 30.11.2028, regardless of the date on which the respective contract is concluded. Accession and/or conclusion of a contract can be made within the…

TENDER BRIEF

TENDER DOCUMENTS